Skip to main content
. 2020 Jun 14;2020:2806042. doi: 10.1155/2020/2806042

Figure 10.

Figure 10

RP11-838N2.3 overexpression could not affect the cell cycle of A549. (a) A549 OE-NC. (b) A549 OE. (c) A549 OE-NC+2 μg/ml cisplatin. (d) A549 OE+2 μg/ml cisplatin. (e) Compared with the A549 OE-NC group, the A549 OE group in the cell ratio of the G0/G1 phase (F = 0.578, P = 0.051), S phase (F = 0.109, P = 0.397), and G2/M phase (F = 0.649, P = 0.992) showed no significant difference. Under the action of cisplatin, compared with those in the A549 OE-NC+2 μg/ml cisplatin group, the cell ratios in the A549 OE+2 μg/ml cisplatin group in the G0/G1 phase (F = 6.438, P = 0.635), S phase (F = 7.866, P = 0.830), and G2/M phase (F = 0.836, P = 0.488) were not distinctly different.